Načítá se...
Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
INTRODUCTION: The long-term efficacy and safety of donepezil 10 mg in patients with dementia with Lewy bodies (DLB) were investigated in a 52-week Phase 3 trial. METHODS: This 52-week study consisted of 16-week randomized placebo-controlled (RCT) and 36-week open-label extension phases. Of 142 DLB p...
Uloženo v:
| Vydáno v: | Alzheimers Res Ther |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4338564/ https://ncbi.nlm.nih.gov/pubmed/25713600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-014-0081-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|